Researcher Profile
Kim, Semi(김세미)
47
Microbiome Convergence Research Center (마이크로바이옴융합연구센터)
- Tel042-860-4228
Keywords Cloud
KRIBB Co-Working
Results 1-20 of 47 (Search time: 0.002 seconds).
| No. | Year | Title | Type |
|---|---|---|---|
| 47 | 2025 | 2025Article Isoxazole-based molecules restore NK cell immune surveillance in hepatocarcinogenesis by targeting TM4SF5 and SLAMF7 linkageSignal Transduction and Targeted Therapy, vol. 10, pp. 15-15J E Kim; H S Kim; W Kim; E H Lee; S Kim; T Kim; E A Shin; K H Pyo; H Lee; S H Jin, et al. |
Article |
| 46 | 2025 | 2025Article Cooperation between ZEB2 and SP1 upregulates PD-L1 and CCL2 to promote the immunosuppressive activity of tumor cellsInternational Journal of Oncology, vol. 67, no. 5, pp. 95-95Dongjoon Ko; Yunhee Lee; Junghwa Yoon; Eun Kyoung Choi; Donghwan Jang; Semi Kim |
Article |
| 45 | 2025 | 2025Article TMEM52B-derived peptides inhibit generation of soluble E-cadherin and EGFR activity to suppress colon cancer growth and early metastasisJournal of Translational Medicine, vol. 23, pp. 146-146Yunhee Lee; Dongjoon Ko; Junghwa Yoon; Semi Kim |
Article |
| 44 | 2024 | 2024Article Association between hepatocyte TM4SF5 expression and gut microbiome dysbiosis during non-alcoholic fatty liver disease developmentLife Sciences, vol. 358, pp. 123164-123164Y D Pinanga; K H Pyo; E A Shin; H Lee; E H Lee; W Kim; S Kim; J E Kim; Semi Kim; J W Lee |
Article |
| 43 | 2023 | 2023Article TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancerExperimental and Molecular Medicine, vol. 55, no. 4, pp. 716-724Semi Kim |
Article |
| 42 | 2022 | 2022Article Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer modelsMolecular Therapy-Oncolytics, vol. 24, pp. 452-466Dongjoon Ko; E Kim; E A Shin; S H Nam; Junghwa Yoon; Jin-Sook Lee; Yunhee Lee; S Park; K Ha; S Y Choi, et al. |
Article |
| 41 | 2022 | 2022Article Bioconjugated thymol-zinc oxide nanocomposite as a selective and biocompatible antibacterial agent against Staphylococcus speciesInternational Journal of Molecular Sciences, vol. 23, no. 12, pp. 6770-6770J Shin; A Naskar; Dongjoon Ko; Semi Kim; K S Kim |
Article |
| 40 | 2022 | 2022Article TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypesCellular and Molecular Life Sciences, vol. 79, no. 1, pp. 49-49H Sun; E Kim; J Ryu; H Lee; E A Shin; M Lee; H Lee; J H Lee; J H Yoon; D G Song, et al. |
Article |
| 39 | 2022 | 2022Article Systemic TM4SF5 overexpression in ApcMin/+ mice promotes hepatic portal hypertension associated with fibrosisBMB Reports, vol. 55, no. 12, pp. 609-614J Lee; E Kim; M K Kang; J Ryu; J E Kim; E A Shin; Y Pinanga; K H Pyo; H Lee; E H Lee, et al. |
Article |
| 38 | 2021 | 2021Article TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activityJournal of Experimental & Clinical Cancer Research, vol. 40, no. 1, pp. 58-58Yunhee Lee; Dongjoon Ko; Junghwa Yoon; Y H Lee; Semi Kim |
Article |
| 37 | 2021 | 2021Article A new surface charge neutralizing nano-adjuvant to potentiate polymyxins in killing Mcr-1 mediated drug-resistant Escherichia coliPharmaceutics, vol. 13, no. 2, pp. 250-250H Cho; A Naskar; S Lee; Semi Kim; K S Kim |
Article |
| 36 | 2021 | 2021Article Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progressionJournal of Pathology, vol. 253, pp. 55-67J Ryu; E Kim; M K Kang; D G Song; E A Shin; H Lee; J W Jung; S H Nam; J E Kim; H J Kim, et al. |
Article |
| 35 | 2021 | 2021Article Bovine serum albumin-immobilized black phosphorus-based γ-Fe2O3 nanocomposites: a promising biocompatible nanoplatformBiomedicines, vol. 9, no. 8, pp. 858-858A Naskar; S Lee; Dongjoon Ko; Semi Kim; K S Kim |
Article |
| 34 | 2021 | 2021Article TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1Journal of Experimental & Clinical Cancer Research, vol. 40, pp. 372-372Yunhee Lee; Junghwa Yoon; Dongjoon Ko; Minyeong Yu; S Lee; Semi Kim |
Article |
| 33 | 2020 | 2020Article A new nano-platform of erythromycin combined with Ag nano-particle ZnO nano-structure against methicillin-resistant Staphylococcus aureusPharmaceutics, vol. 12, no. 9, pp. 841-841A Naskar; S Lee; Yunhee Lee; Semi Kim; K S Kim |
Article |
| 32 | 2020 | 2020Article A nontoxic biocompatible nanocomposite comprising black phosphorus with Au-γ-Fe2O3 nanoparticlesRsc Advances, vol. 10, pp. 16162-16167A Naskar; Semi Kim; K S Kim |
Article |
| 31 | 2019 | 2019Article Transmembrane 4 L Six Family Member 5 Senses Arginine for mTORC1 SignalingCell Metabolism, vol. 29, no. 6, pp. 1306-1319J W Jung; S J Y Macalino; M Cui; J E Kim; H J Kim; D G Song; S H Nam; Semi Kim; S Choi; J W Lee |
Article |
| 30 | 2019 | 2019Article Anti-cancer activity of the novel 2-hydroxydiarylamide derivatives IMD-0354 and KRT1853 through suppression of cancer cell invasion, proliferation, and survival mediated by TMPRSS4Scientific Reports, vol. 9, pp. 10003-10003Solbi Kim; Dongjoon Ko; Yunhee Lee; S Jang; Y Lee; I Y Lee; Semi Kim |
Article |
| 29 | 2018 | 2018Article VBP1 represses cancer metastasis by enhancing HIF-1α degradation induced by pVHLFEBS Journal, vol. 285, no. 1, pp. 115-126J A Kim; D K Choi; J S Min; I Kang; J C Kim; Semi Kim; J K Ahn |
Article |
| 28 | 2018 | 2018Article Preparation of siRNA encapsulated nanoliposomes suitable for siRNA delivery by simply discontinuous mixingBiochimica et Biophysica Acta-Biomembranes, vol. 1860, no. 6, pp. 1318-1325A A Mokhtarieh; Jieun Lee; Semi Kim; Myung Kyu Lee |
Article |